Amneal Pharmaceuticals (AMRX) Reports Next Week: Wall Street Expects Earnings Growth Amneal (AMRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Amneal Pharmaceuticals (AMRX) Beats Q2 Earnings and Revenue Estimates Amneal (AMRX) delivered earnings and revenue surprises of 14.29% and 6.75%, respectively, for the quarter ended June 2024. Do the…
Global Muscle Relaxant Drugs Market Size To Worth USD 5.91 Billion By 2033 | CAGR Of 4.24% The Global Muscle Relaxant Drugs Market Size was Valued at USD 3.90 Billion in 2023 and the Worldwide Muscle Relaxant…
Global Parkinson’s Disease Treatment Market Size To Worth USD 9.14 Billion By 2033 | CAGR Of 6.41% The Global Parkinsons Disease Treatment Market Size was Valued at USD 4.91 Billion in 2023 and the Worldwide Parkinsons Disease…
Canadian Pharma Stocks: 5 Biggest Companies in 2024 The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…
Drugmaker Amneal agrees to $270 million U.S. opioid settlement Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it…
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates Amneal (AMRX) delivered earnings and revenue surprises of 55.56% and 5.80%, respectively, for the quarter ended March 2024. Do the…
Global Testosterone Replacement Therapy Market Size To Worth USD 2.93 Billion By 2033 | CAGR Of 4.0% The Global Testosterone Replacement Therapy Market Size was Valued at USD 1.98 Billion in 2023 and the Worldwide Testosterone Replacement…
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan Bausch (BHC) initiates litigation against Amneal Pharmaceuticals and its subsidiaries over a generic version of its lead drug Xifaxan.…
Global Pregabalin Market Size To Worth USD 2.18 Billion By 2033 | CAGR of 2.82% The Global Pregabalin Market Size was Valued at USD 1.65 Billion in 2023 and the Worldwide Pregabalin Market Size is…
Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023 By Investing.com Earnings call: Amneal Pharmaceuticals sees growth and diversification in 2023…
Amneal Pharmaceuticals (AMRX) Beats Q4 Earnings Estimates Amneal (AMRX) delivered earnings and revenue surprises of 100% and 2.17%, respectively, for the quarter ended December 2023. Do the…